
    
      This is an open (for the administration route) and double-blind (only for the two dosages
      administered at year 0 by using the investigational administration route) randomized trial
      conducted in subjects aged 18 to 60 years. The subjects will receive three vaccine injections
      at 1-year interval.
    
  